GB2259302A - Mutant nitrogen fixing bacterium - Google Patents
Mutant nitrogen fixing bacterium Download PDFInfo
- Publication number
- GB2259302A GB2259302A GB9119255A GB9119255A GB2259302A GB 2259302 A GB2259302 A GB 2259302A GB 9119255 A GB9119255 A GB 9119255A GB 9119255 A GB9119255 A GB 9119255A GB 2259302 A GB2259302 A GB 2259302A
- Authority
- GB
- United Kingdom
- Prior art keywords
- gene
- nifl
- nifa
- mutant
- bacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000589152 Azotobacter chroococcum Species 0.000 title claims abstract description 8
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 71
- 101150004139 nifL gene Proteins 0.000 claims abstract description 66
- 241000894006 Bacteria Species 0.000 claims abstract description 55
- 101150035327 nifA gene Proteins 0.000 claims abstract description 41
- 101150108916 nifA1 gene Proteins 0.000 claims abstract description 32
- 108010020943 Nitrogenase Proteins 0.000 claims abstract description 26
- 230000035772 mutation Effects 0.000 claims abstract description 23
- 230000000694 effects Effects 0.000 claims abstract description 20
- 230000001105 regulatory effect Effects 0.000 claims abstract description 5
- 230000004048 modification Effects 0.000 claims abstract 2
- 238000012986 modification Methods 0.000 claims abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 56
- 241000589149 Azotobacter vinelandii Species 0.000 claims description 40
- 241000196324 Embryophyta Species 0.000 claims description 32
- 229910052757 nitrogen Inorganic materials 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 27
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 26
- 238000004519 manufacturing process Methods 0.000 claims description 17
- 229910021529 ammonia Inorganic materials 0.000 claims description 13
- 108090001090 Lectins Proteins 0.000 claims description 9
- 102000004856 Lectins Human genes 0.000 claims description 9
- 238000003780 insertion Methods 0.000 claims description 9
- 230000037431 insertion Effects 0.000 claims description 9
- 239000002523 lectin Substances 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 8
- 230000012010 growth Effects 0.000 claims description 7
- 241000589151 Azotobacter Species 0.000 claims description 6
- 241000894007 species Species 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 241000589180 Rhizobium Species 0.000 claims description 3
- 239000002689 soil Substances 0.000 claims description 3
- 241000219793 Trifolium Species 0.000 claims description 2
- 239000000443 aerosol Substances 0.000 claims description 2
- 238000012261 overproduction Methods 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 46
- 239000012634 fragment Substances 0.000 description 17
- 230000014509 gene expression Effects 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 12
- 239000002609 medium Substances 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 10
- 238000013518 transcription Methods 0.000 description 10
- 230000035897 transcription Effects 0.000 description 10
- 238000011144 upstream manufacturing Methods 0.000 description 10
- 229930006000 Sucrose Natural products 0.000 description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000005720 sucrose Substances 0.000 description 8
- 230000029142 excretion Effects 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 238000012217 deletion Methods 0.000 description 6
- 230000037430 deletion Effects 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 102000005936 beta-Galactosidase Human genes 0.000 description 4
- 108010005774 beta-Galactosidase Proteins 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 101150066555 lacZ gene Proteins 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 241000588747 Klebsiella pneumoniae Species 0.000 description 3
- SXTAYKAGBXMACB-DPVSGNNYSA-N L-methionine sulfoximine Chemical compound CS(=N)(=O)CC[C@H](N)C(O)=O SXTAYKAGBXMACB-DPVSGNNYSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 102000005396 glutamine synthetase Human genes 0.000 description 3
- 108020002326 glutamine synthetase Proteins 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 101150012415 ntrC gene Proteins 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 102100027674 CTD small phosphatase-like protein Human genes 0.000 description 2
- 101100007969 Homo sapiens CTDSPL gene Proteins 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 108090000913 Nitrate Reductases Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 241000219843 Pisum Species 0.000 description 2
- 241000589194 Rhizobium leguminosarum Species 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- BABWHSBPEIVBBZ-UHFFFAOYSA-N diazete Chemical compound C1=CN=N1 BABWHSBPEIVBBZ-UHFFFAOYSA-N 0.000 description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 2
- 101150065098 glnG gene Proteins 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 101150046736 ntrB gene Proteins 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 229940083618 sodium nitroprusside Drugs 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 101150098072 20 gene Proteins 0.000 description 1
- 241000192542 Anabaena Species 0.000 description 1
- 101100154577 Arabidopsis thaliana NTR1 gene Proteins 0.000 description 1
- 241000589938 Azospirillum brasilense Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000018656 Mitogen Receptors Human genes 0.000 description 1
- 108010052006 Mitogen Receptors Proteins 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 108010025915 Nitrite Reductases Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 230000010757 Reduction Activity Effects 0.000 description 1
- 241000191023 Rhodobacter capsulatus Species 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 244000042324 Trifolium repens Species 0.000 description 1
- 235000010729 Trifolium repens Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- -1 ammonium cations Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 238000004178 biological nitrogen fixation Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000003831 deregulation Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- XEYBHCRIKKKOSS-UHFFFAOYSA-N disodium;azanylidyneoxidanium;iron(2+);pentacyanide Chemical compound [Na+].[Na+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].[O+]#N XEYBHCRIKKKOSS-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- RSAZYXZUJROYKR-UHFFFAOYSA-N indophenol Chemical compound C1=CC(O)=CC=C1N=C1C=CC(=O)C=C1 RSAZYXZUJROYKR-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 101150095858 nifB gene Proteins 0.000 description 1
- 101150109846 nifH2 gene Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 101150011750 rpoN gene Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- NESLWCLHZZISNB-UHFFFAOYSA-M sodium phenolate Chemical compound [Na+].[O-]C1=CC=CC=C1 NESLWCLHZZISNB-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 101150001289 vnfH gene Proteins 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0095—Oxidoreductases (1.) acting on iron-sulfur proteins as donor (1.18)
-
- C—CHEMISTRY; METALLURGY
- C05—FERTILISERS; MANUFACTURE THEREOF
- C05F—ORGANIC FERTILISERS NOT COVERED BY SUBCLASSES C05B, C05C, e.g. FERTILISERS FROM WASTE OR REFUSE
- C05F11/00—Other organic fertilisers
- C05F11/08—Organic fertilisers containing added bacterial cultures, mycelia or the like
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/743—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Agrobacterium; Rhizobium; Bradyrhizobium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y118/00—Oxidoreductases acting on iron-sulfur proteins as donors (1.18)
- C12Y118/06—Oxidoreductases acting on iron-sulfur proteins as donors (1.18) with dinitrogen as acceptor (1.18.6)
- C12Y118/06001—Nitrogenase (1.18.6.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/065—Azotobacter
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
A mutant nitrogen fixing bacterium wherein nitrogenase activity is controlled by a nifA or nifA-like gone which is in turn regulated solely by a nifL or nifL-like gene characterised by the modification that it has a mutation in the nifL or nifL-like gene, but a functional nifA or nifA-like gene. The bacterium may be of the genes Azobacter.
Description
AMMONIA PRODUCTION
Field of the invention
This invention is in the field of ammonia production by nitrogen fixing bacteria.
Description of the prior art
Many microorganisms are able to assimilate the major bioelements (i.e. carbon, nitrogen, sulphur, hydrogen and oxygen) in an inorganic form. The ability to use N2 as a nitrogen source is restricted to prokaryotes, and is relatively rare even among this group. The enzyme system responsible for N2 fixation is called nitrogenase. Biosynthesis of the components of the nitrogenase system is determined by 15 to 20 different nif genes.
Free-living nitrogen fixing bacteria fix an amount of atmospheric nitrogen sufficient for their own needs. Evidence for this is that significant amounts of ammonia are rarely found in the culture medium (in laboratory cultures) or environment (in the soil) of nitrogen fixing organisms. Regulatory mechanisms controlling nif gene transcription and/or nitrogenase activity ensure that cellular energy is not wasted by the fixation of more nitrogen than is necessary to meet the demands of bacterial cell growth and viability. In particular, excess environmental ammonia or oxygen prevents expression of nif genes in free living diazotrophs (nitrogen fixing bacteria). Ammonia makes nitrogenase unnecessary and oxygen inactivates the enzyme.Since these bacteria produce ammonia for assimilation by plants in the form of ammonium cations (NH4+), the term "ammonium" is used hereinafter for brevity.
Attempts to induce ammonium excretion have up to now centered on physiological suppression of genetic manipulation of the enzymes involved in ammonium assimilation. Treatment of cyanobacteria, with L-methionine-DL-sulfoximine (MSX), an inhibitor of glutamine synthetase (GS), resulted in the excretion of 0.3 to 7 mM NH4+ into the growth medium, (Musgrove et 1982, Biotech. Letters, 4, 647-652, Newton et al., 1985,
Biochim, Biophys. Acta, 809, 44-50 and Ramos et al., 1984, Appl.
Environ. Microbiol., 48, 114-118). Mutants of Anabaena resistant to MSX or the NH4+ analogue ethylene diamine excreted up to 1.6 mM NH4+, (Polukina et al., 1982, Microbiology, 51, 90-95, Spiller et al., 1986, J. Bacteriol., 165, 412-419 and Thomas et al., 1990
Appl. Environ Microbiol., 56, 3499-3504). Among eubacteria, ammonium excretion was reported to occur in Gln or Gln asm-l mutants of Klebsiella pneumoniae, (Anderson et A., 1977, J.Gen.
Microbiol., 103, 107-122 and Shanmugam et al., 1975, Proc. Natl.
Acad. Sci. USA. 72, 136-139), in mutants of Rhodobacter capsulatus and Azospirillum brasilense altered in the production of GS, (Wall et ii., 1979, J. Bacteriol., 137, 1459-1463), and in methylamine resistant mutants of Azotobacter vinelandii, (Gordon et al., 1983, Can. J. Microbiol., 29, 973-978). Although significant ammonium excretion has been observed, these chemically treated or mutated organisms require supplementation of large amounts of the amino acid glutamine for growth.
The regulatory pathways and mechanisms involved in the repression of nif genes by ammonium have been extensively characterized in the free living diazotrophs Klebsiella pneumoniae and Azotobacter vinelandii. Of central importance in both organisms (and other gram negative nitrogen fixing bacteria) is that a positivelyacting regulatory protein NIFA is required to activate transcription of the other nif genes which are necessary for nitrogenase structure and activity. In K. pneumoniae, ammonium represses nitrogenase synthesis by preventing either the activity or synthesis of NIFA, which occurs by two separate mechanisms:
The nifA gene is adjacent to and downstream of nifL (thus forming the nifLA operon) and these two genes are co-expressed. The NIFL protein binds to and inactivates NIFA if ammonium is present even at relatively low levels ( > approx. 5pM).At higher levels of ammonium ( > approx. 200pM), expression of the nifLA operon does not occur and so the NIFA protein is not synthesized.
Transcription of nifLA requires phosphorylated NTRC protein but this protein is dephosphorylated and hence inactive in cells grown with ammonium. Thus in K. pneumoniae, repression of nitrogenase synthesis by ammonium occurs at two levels, inactivation of NIFA by NIFL and prevention of nifA expression by dephosphorylated NTRC.
Nitrogen fixation in A. vinelandii is determined by the presence of three biochemically and genetically distinct nitrogenase enzymes, each of which is synthesized under different conditions of metal supply. The molybdenum nitrogenase gene which is similar to the enzyme purified from a number of other nitrogen fixing organisms, requires 15 - 20 gene produces for its structure and activity. In A. vinelandii as In K. pneumoniae expression of the nif genes requires active NIFA product. Unlike in K. pneumoniae however, NTRC is not required for nitrogen fixation which implies that NTRC is not necessary for nifA expression.
DNA sequencing of the nifA region of A. vinelandii revealed a gene whose translation product was similar to NIFA of K.
pneumoniae. The DNA sequence of 200bp upstream of nifA revealed a partial open reading frame (ORF) which predicted a protein with homology to the C-terminal regions of the nifL and ntrB gene products of K. pneumoniae. (Bennett et al., 1986, Mol.
Microbiol., 2, 315-321).
It would be desirable to be able to induce ammonium production in these nitrogen fixing bacteria for a variety of purposes. Attempts to de-regulate nitrogenase synthesis in Klebsiella pneumoniae by mutating either the nifL or ntrC genes were unsuccessful. The resulting nifL mutant was only weakly able to escape ammonium repression, and the ntrC mutant was nifA-, which means that nitrogenase synthesis does not occur and the organism is unable to fix nitrogen at all.
The problem is that attempts to produce ammonia from nitrogen fixing bacteria by de-regulation of nitrogenase production have been unsuccessful and although attempts to produce ammonia by genetically manipulating ammonium assimilation enzymes have been successful, the organism itself is unable to grow normally.
Summary of the Invention
It has surprisingly been found that in organisms wherein nitrogenase synthesis is controlled by nifA or nifA-like genes which are in turn regulated only by nifL or nifL-like genes, mutations in the nifL or nifL-like genes result in mutant strains of bacteria which produce and excrete significant amounts of ammonium. Surprisingly, these mutants grow as well as the parental strains.
Description of the preferred embodiments
This invention is applicable to any species of nitrogen fixing bacteria which contain nifL or nifL-like genes as part of their nitrogenase enzyme system, said nifL or nifL-like genes solely controlling the transcription of nifA or nifA-like genes which in turn regulate transcription of other nif genes necessary for nitrogenase structure and activity. For convenience hereinafter, nifL or nifL-like genes will be referred to simply as nifL and likewise nifA or nifA-like genes will be referred to as nifA.
According to a first aspect of the invention there is provided a mutant of a nitrogen fixing bacterium as described above, characterised in that it contains a mutant nifL gene and a functional nifA gene.
The preferred bacteria are those which normally have strong plant associations, either by being present in the rhizosphere or by being attached to plant roots or living inside plant roots or stems (so called systemic endophytes), or all bacteria from the genus Azotobacter whether plant associated or not. Particularly preferred bacteria are from the genus Azotobacter, especially
Azotobacter vinelandii. The most preferred strain is the subject of a patent deposit, deposited in accordance with the provisions of the Budapest Treaty at the National Collection of Industrial and Marine Bacteria Ltd., (NCIMB), 23 St. Machen Drive, Aberdeen,
AB2 lRY, Scotland, United Kingdom, on 30 August 1991 and given the accession number 40438, or a mutant or variant thereof having the desired functions of growth and production of ammonia.
According to a second aspect of the invention, there is provided a process for the isolation of the nifL gene by, for example, standard heterologous hybridisation techniques, from the nitrogen fixing bacteria described hereinbefore, the construction of the mutations in the nifL gene, and the reintroduction of nifL mutations into the chromosome of the bacteria to replace the wild-type nifL gene. It is necessary that mutations inactivate the function of the nifL gene product but do not interfere with expression of the downstream nifA gene. Examples are presented which show that nifL mutants continue to produce nitrogenase and express nitrogenase genes (nifHDK) in the presence of high levels of ammonium in the medium.
It will be apparent to those skilled in the art that mutations may be carried out in a variety of ways. The mutations may be carried out by the addition of extra genetic material into the nifL gene (so called "insertion mutants"), deletion of part of the nifL gene (so called "deletion mutants") or exchange of nucleic acid sequences rendering the protein non-functional for those rendering the protein functional. Such exchanges may be as large as the nifL gene itself, or an exchange of a single base in the DNA coding for the gene (so called "point mutation") may be sufficient. Techniques for carrying out the mutations will be apparant to those skilled in the art.
In the bacteria of the invention, the nifL and nifA genes are normally found in an operon, under the control of one promoter, with nifL transcription occurring prior to nifA transcription.
The functionality of the nifA gene must be preserved in the mutant. That is, the nifA gene must be retained as in the parent organism or, if altered, the alteration must be non-interfering.
It is important that the mutation does not prevent nifA production, for example, by insertion of a point mutation into nifL which introduces a termination signal or by introduction of a polar mutation. The mutation must therefore be one which does not interfere with mRNA production. The nifA gene has its own
Shine-Dalgarno sequence and hence the mutation in nifL need not be in-frame with the reading frame of nifA, since transcription of nifA will continue as normal, despite mutation of nifL. It is known that the nifLA operon promoter is such that nifA is produced at levels which the bacteria find physiologically tolerable. Over-production of nifA by, for example, mutations which result in the production of a strong promoter, is detrimental to the cell. Therefore mutations in the nifL gene must not result in replacement of the natural gene promoter with a stronger promoter.The promoter of the nifLA operon must not be stronger than the natural promoter found in the wild type bacterium and preferably is the natural promoter.
When carrying out the invention in the deposited strain of
Azotobacter vinelandii it is therefore preferable, in order to achieve normal expression of nifA in the nifL mutant, to retain a 200 base pair region between the BglII and SmaI sites upstream of the nifL coding region. This region carries the promoter of the nifLA operon in the A. vinelandii strain.
According to a third aspect of the invention there is also provided a mutated nifL gene which may be inserted into wild type bacteria in order to render them nifL-. Preferably the mutant gene is from Azotobacter and is inserted into other Azotobacter species. More preferably, the gene is from the deposited strain of Azotobacter vinelandii.
According to a fourth aspect of the invention there is provided a method of controlling the level of ammonium production by bacteria described hereinbefore. It is known that the increase in pH of the culture medium which occurs concomitantly with ammonium excretion, limits the amount of ammonium excreted because the high pH inactivates nitrogenase. Control of pH, either by increased buffer capacity of the medium or by removal of the ammonium as it is excreted, can be utilized to give higher levels of ammonium production, or lower levels as required, for example in the use of nifL mutants of A. vinelandii, or other nitrogen fixing organisms described hereinbefore to produce ammonium whilst cells are immobilized on calcium alginate particles or beads.
The invention is particularly useful for those nitrogen fixing bacteria which are normally abundant in the rhizosphere or found associated with specific plants, either by being bound to glycoproteins such as lectin on plant roots or actually living inside plant roots and stems (systemic endophytes).
According to a fifth aspect of the invention, there is provided a method of providing plants with a source of fixed nitrogen by introduction of mutant nitrogen fixing-bacteria as described hereinbefore into nitrogen-fixing association with plant tissue (including parts of plants, seed, whole plants etc.). Nitrogen-fixing association with plants can manifest itself in several ways. Once introduced into nitrogen-fixing association with plants the bacteria may be present in the rhizosphere, or be associated with plants as described above.
The mutant nitrogen fixing bacteria may be introduced to the plant tissue in a variety of ways. They can be applied to the plants themselves before or after planting, the soil before or after planting has occurred or to seeds. Conveniently the bacteria are applied as an aerosol or in a liquid or solid form.
The mutant bacteria may be of a totally different family, genus or species to the wild type bacteria normally found in nitrogen-fixing association with plants.
The mutations in the nifL gene may be introduced by mutating the wild type bacterium itself by methods hereinbefore described or may be introduced by gene replacement. The bacteria may be mutants of the wild type bacteria which are normally found associated with plants. Gene replacement involves the replacement of a gene from one organism with, in this case, a mutant nifL gene from another organism. Preferably, the two organisms are of the same family or genus, more preferably of the same species or strain.
The invention also provides a way of introducing a source of fixed nitrogen to those plants to which there may be no nitrogen fixing bacterium normally associated. Preferably the mutant bacteria providing the source of ammonium to these plants is
Azotobacter vinelandii, which is able to bind to lectins present on plant roots. Such Azotobacter vinelandii capable of lectin binding is constructed according to the teaching described by
Bishop et al., 1977 Science, 198, 938-939 and Diaz et Nature, 1989, 338, 579-581. These papers describe the construction of A. vinelandii strains that bind to lectins produced by two species of leguminous plants, Trifolium repens and Pisum sativa.The genes important for providing the ability of lectin binding will be transferred from Rhizobium trifolium and R. leguminosarum to A. vinelandii nifL mutant strains. The gene for lectin production from Pisum sativa will be transformed into plant cells of a variety of species as described in Bishop et al., and Diaz et al., above. The production of P. sativa lectin receptors in A. vinelandii will allow it to bind to roots or other tissues of plants carrying genes that determine lectin binding from Rhizobium leguminosarum. The binding of
A. vinelandii nifL mutants to plant roots or other tissues may allow the provision of fixed nitrogen from bacteria directly to plants.
Description of the drawings
Figure 1 shows a restriction map of the Azotobacter
vinelandii nifLA operon, and construction of plasmids.
Figure 2 shows the levels of ammonia production by
mutant and wild type Azotobacter vinelandii.
Embodiments of the invention will be described by way of
Example only.
EXAMPLE 1 : Growth of A. vinelandii
Strains of A. vinelandii were grown aerobically at 30"C in
Burk's sucrose medium as described previously by Toukdarian et al., 1986, Embo J., 5, 399-407. Liquid 25ml cultures, contained in 125ml flasks, were incubated on a rotary shaker (180rpm).
Competence medium (CM) was Burk's sucrose medium prepared without the addition of Fe and Mo salts. LB medium was used for growing
E. cold. Antibiotics for selection of resistance genes on plasmids or in genomic transformants were added at concentrations previously reported (Santero et al., 1988, Mol. Microbiol., 2, 303-314).
EXAMPLE 2 : Isolation of an A. vinelandii genomic fragment carrying the region upstream of nifA
About 300bp of the 3'-end of a gene encoding a protein with partial sequence homology to the C-termini of the nifL and ntrB gene products of K. pneumoniae had been cloned in the plasmid pDBlS0 and sequenced by Bennett et al., 1988, Mol. Microblol., 2, 315-321. In order to isolate and clone the entire upstream gene, plaques from a lambda library of A. vinelandii genomic DNA were screened for hybridization to a DNA probe labelled with 32P-dCTP.This probe was a 1.2Kb SalI-Kp I fragment from pDBlS0 which contains the 3'-end of the nifL/ntrB-like gene and the 5'-end of nifA (see Fig. 1) (Bennett et al., 1988, Mol.
Microbiol., 2, 315-321). An approximately 12.5Kb EcoRI fragment was identified in the insert DNA prepared from the progeny of one hybridizing plaque; it was subcloned into pBR325 to give pAB21.
(This 12.5Kb fragment corresponded in size to a genomic fragment previously reported to hybridize to a nifA probe; a nifA::TnS mutant, MV3, contained a new nifA-hybridizing fragment of about l9Kb in size (Santero et al., 1988 Mol. Microbiol, 2, 303-814).
A restriction map of the insert in pAB21 showed that one end of the 12.5KB EcoRl fragment had restriction sites corresponding to those reported by Bennett et al. (see above) for pDBl5O. Part of this fragment and the nifA/nifB region, and subclones derived for this work, are shown in Fig. 1.
Methods for blotting and screening the lambda library and for cloning DNA fragments were standard procedures described in
Sambrook et al., 1989, Molecular Cloning, Cold Spring Harbor
Laboratory Press. Cold Spring Harbor, and by instructions provided by suppliers of restriction enzymes.
EXAMPLE 3 : Construction of a nifA-lacZ fusion gene
The transposon Tn5-B21 carrying lacZ and a gene encoding tetracycline resistance (Tcr) was introduced into E. coli carrying pAB8, (a SmaI-SphI fragment of pABS in pACYC177), (see
Fig. 1) by infection with X ::Tn5-B21, (Simonet et al. 1989,
Gene, 80, 161-169). Plasmid derivatives carrying Tn5-B21 insertions were isolated and characterized as described previously. (Thomas et al., Appl. Environ. Microbiol., 56, 3499-3504).
EXAMPLE 4 : Transformation of A. vinelandii
Competent cells were prepared by a simplification of a method described previously (Page et al., 1978, Can. J. Microbiol., 24 1590-1594): instead-of growing cells in liquid competence medium (CM) prior to transformation, cells were resuspended directly from the second round of growth on CM agar into lml of liquid CM + 16mM MgS04 to a density of about 108 cells ml1. Approximately 50p1 of resuspended cells were spotted onto a CM agar plate and 0.1-lpg of plasmid DNA was mixed with the cells. After incubation at 30C for two days, approximately 5 x 107 cells were transferred to selective medium containing appropriate antibiotics. Cells not mixed with DNA were plated as controls.
Transformants arose at 104 105 (pg DNA)-1.
EXAMPLE 5 : Isolation of the KIXX Cassette
The region upstream of nifA in A. vinelandii was identified and cloned as described in Example 1. The KIXX cassette, containing the KMr gene (aph) from Tn5, was isolated as a 1.5Kb SmaI fragment from the plasmid pUC4-KIXX (Pharmacia Ltd., UK).
This fragment was ligated with pAB26, which had been digested with SalI and SmaI; the SalI overhang was blunt-ended using
Klenow polymerase and deoxynucleotides (Fig. 1). The resulting plasmids pAB29 and pAB30, with the KIXX cassette inserted in opposite orientations, were transformed as described in Example 4 into two strains of A. vinelandii, wild type UW136 and the nifH-lacZ fusion strain MV101. Kmr transformants were screened for resistance to carbenicillin (Cbr); CBs derivatives were assumed to have arisen from a double crossover recombination event in which the wild-type nifL/ntrB-like gene was replaced by the KIXX-containing DNA. Kmr CBS transformants of UW136 were obtained with pAB29 but not with pAB30. The pAB29-derived strain, MV376, was Nif+.Southern blots of DNA from MV376,
MV378, and MV380, digested with SalI, were hybridized to a 32P-labelled probe from the mutated region (the 0.3Kb SalI-SphI fragment from pAB31; see Fig. 1). Southern hybridization experiments showed that in all three mutants, the 3.5Kb wild-type
SalI fragment was absent and replaced by a 6.2Kb hybridizing fragment.
Although the KIXX insertion in both orientations in the nifL gene of A. vinelandii resulted in a Nif+ phenotype, Insertions of
Tn5 or the Q (transcription terminator) cassette in A. vinelandii nifL resulted in a Nif phenotype. Therefore, the nifLA genes are probably cotranscribed in A. vinelandii as in K. pneumonlae.
Although the KIXX aph cartridge inserted upstream to oppose transcription can inhibit expression of downstream genes in
A. vinelandii the nifA gene in the nifL (KIXX) mutants MV376 and
MV378 is obviously expressed. This could arise from unexpected promoter activity in the cassette or from promoter-like sequences generated by the KIXX insertion in the nifL region.
Insertion of KIXX in the orientation where expression of aph was in the same direction as nifA resulted in somewhat higher constitutive levels of ss-galactosidase (MV380) than when inserted in the opposite direction (MV378). However, it was not possible to construct a Nif+ nifL2-KIXX derivative in the wild-type equivalent to MV380, which, as it carries a nifH-lacZ fusion, is Nif-. Therefore excessive expression of nifA driven by the very strong aph promoter is probably lethal in a Nlf+ A. vinelandii background, possibly due to diversion of too much ATP towards nitrogenase synthesis and activity or to NH4+ toxicity.
EXAMPLE 6 : Enzvme assays
Nitrogenase and ss-galactosidase activities were measured as described previously. (Sambrook et al., 1989, "Molecular
Cloning". Cold Spring Harbor Laboratory Press, Cold Spring
Harbor, and Walmsley et al., 1991, Appl. Environ. Microbiol., 57, 522-524).
The results of these assays are shown in Table 1 below:
TABLE 1
Nitrogenase and ss-galactosidase activities in
wild-type and nifL mutants of A. vinelandii
Strain Genotype -N +NH4+
UW136 wild-type 48a 0
MV376 nifLl:KIXX 48 46 MV101 nifHl:lacZ 15841b 432
MV378 nifHl:lacZ 11967 3772 nifHl :KIXX MV380 nifHl:lacZ 15384 6474 nifH2:KIXX -N N free medium.
a Nitrogenase activity in UW136 and MV376: measured as
acetylene reduction (nmol ethylene produced mi n'1 (mg
protein)-1).
b (3-galactosidase activity in MV101, MV378, MV380: measured as
Miller units (26).
Each value is the mean from 2 - 3 independent determinations; variation was < 10% from the mean.
The data in Table 1 show that MV376 was Nif+ and expressed wild-type acetylene reduction activity both in N-free medium and in medium with ammonium at 15mM, a concentration that repressed nitrogenase activity in the wild-type strain UW136. Similarly, both MV378 and MV380 expressed ss-galactosidase activity in the absence or presence of ammonium whereas activity in the nifL+ strain MV101 was repressed by 15mM ammonium.
Other activities repressed by ammonium in A. vinelandil are those of nitrate reductase and nitrite reductase, (Luque fte al., 1987, Arch. Microbiol., 148, 231-235), the expression of which requires both the ntrC and rpoN gene products, (Luque et Supra, Santero fte al., 1986, J. Bacteriol., 166, 541-544 and
Toukdarian et al., 1986, EMBO J., 5, 399-407). The KIXX insertion mutation had no effect on normal regulation of nitrate reductase; this activity was present in N03'-grown but not
NH4+(+ N03~)-grown cultures of both wild-type UW136 and mutant
MV376 (data not shown).
These results demonstrate that the gene upstream of nifA in
A. vinelandii mediates ammonium repression of nif gene expression but not of at least one other gene under ammonium control. This phenotype is similar to that of nifL mutants of K. pneumoniae where nifL is located immediately upstream of nifA. Translation of the entire A. vinelandii upstream gene sequence (approximately 1.4kb) shows a protein with greater homology to K. pneumoniae nifL, than to NTRB (31% vs. 24% identity).
EXAMPLE 7 : Ammonium estimation
Culture supernatants of A. vinelandii wild-type strain UW136 and mutant strain MV376 grown on nitrogen were tested for the present of ammonium.
Samples of cultures were taken at different times and centrifuged. 0.5ml of supernatant or filtrate was tested for the presence of ammonium by the indophenol method, (Bergersen, 1980, "Methods for evaluating biological nitrogen fixation", John Wiley & Sons Ltd., London). This consisted of the addition, in order, of a) 0.5ml phenol-sodium nitroprusside solution (phenol, 50g 1-1 + sodium nitroprusside, 0.25g 1-1); b)0.5ml of sodium hypochlorite solution (O.lm); and c) 2ml of distilled water. The mixture was incubated for 30 min at room temperature. Absorbance at 625nm was measured and ammonium concentration estimated from a standard curve obtained with ammonium solutions at various concentrations assayed using the same reagent solution.
The results are drawn in Figure 2, wherein denotes UW136 and o denotes MV376.
In contrast to UW136, MV376 excreted ammonium rather suddenly towards the end of exponential growth. Final amounts measured in
MV376 stationary phase cultures were 5 - 10 mM. Excretion was not limited by carbon source availability because half of the supplied sucrose remained at its cessation.
EXAMPLE 8 : Construction of nifL deletion mutant of A. vinelandii
The plasmid pAB27 carrying the nifL region was digested with
BglII and ligated to a 3.8 Kb BamHI fragment from pJ017 which carries the gene cartridge, sac (Hynes et al., Gene, 1989 78, 111-120. The sac gene confers a sensitivity to sucrose when transferred to certain gram negative bacteria, i.e. organisms carrying the sac gene cannot grow on sucrose-containing media.
The resulting plasmid, pLA5:Sac-Km, carries the sac cartridge which replaces a 585 base pair figill fragment, deleting the 5'-end of the gene and 20 base pairs upstream from the translation start codon. In order to transfer the nifL:sac mutation from pLAS:Sac-Km into the chromosome, the plasmid was transformed into A. vinelandii UW136 and kanamycin-resistant colonies were selected. These were found to be unable to grow on sucrose-containing medium but could grow normally on glucose as carbon source. One colonies was purified several times and had a stable sucrose-sensitive, kanamycin-resistant phenotype. This mutant was MV399. MV399 had a Nif minus phenotype because the sac cartridge insert prevented expression of the downstream nifA gene which is essential for expression of nif genes.
In order to replace the nifL:sac mutation with a nifL deletion mutation uninterrupted by sac DNA, pAB27 was digested with BalII and ligated to itself. Plasmid pLA4 was isolated and found to contain the 585 base pair BglII deletion within the nifL gene. MV399 was transformed with pLA4 and colonies growing on sucrose-containing ammonium-free medium were selected. These Nif plus colonies were also kanamycin-sensitive indicating that the sac-Km cartridge had been replaced. One such colony was purified and tested for ammonium excretion. This strain, MV440, was found to excrete up to l0mM ammonium into the growth medium and the pH of cultures increased to about 8.5 when no further ammonium was excreted. Thus a deletion of the 5'-end of the nifL gene, which does not affect expression of the downstream nifA gene, leads to a mutant strain of A. vinelandii which excretes large amounts of ammonium similar to the phenotype of the nifL:KIXX mutant MV376 described previously.
Claims (22)
1. A mutant nitrogen fixing bacterium wherein nitrogenase activity is controlled by a nifA or nifA-like gene which is in turn regulated solely by a nifL or nifl-like gene characterised by the modification that it has a mutation in the nifL or nifl-iike gene, but a functional nifA or nifA-like gene.
2. A bacterium according to Claim 1 which is of the genus
Azotobacter.
3. A bacterium according to Claim 2 which is of the species
Azotobacter vinelandii.
4. A bacterium according to Claim 3 which is the strain deposited at the National Collection of Industrial and Marine
Bacteria Ltd., Aberdeen, Scotland, UK on 31 August 1991 under the
Accession number 40438 or a mutant or variant thereof having the same function of overproduction of ammonia.
5. A process for the production of a mutant bacterium according to Claim 1, 2, 3 or 4 comprising the steps of isolating the nifL gene of a parent nitrogen-fixing bacterium wherein nitrogenase activity is controlled by a nifA or nifA-like gene which is in turn regulated solely by a nifL or nifl-like gene, mutating the nifL gene and replacing the nifL gene of a parent nitrogen-fixing bacterium by the mutated nifL or nifL-like gene, while preserving the functionality of the nifA or nifA-like gene.
6. A process according to Claim 5 wherein a nifL gene from one bacterium, (recipient) is replaced by a mutant nifL gene from another (donor) bacterium.
7. A process according to Claim 6 wherein the donor and recipient bacteria are of the same genus or family.
8. A process according to Claim 7 wherein the donor and recipient bacteria are of the same species.
9. A process according to Claim 7 wherein the donor and recipient bacteria are Azotobacter.
10. A process according to Claim 8 wherein the donor and recipient bacteria are Azotobacter vinelandii.
11. A process according to Claim 8 wherein the donor and recipient bacteria are the Azotobacter vinelandii strain deposited at National Collection of Industrial and Marine
Bacteria Ltd., Aberdeen, Scotland, UK on 30th August 1991 under the Accession number 40438 or a mutant or variant thereof having the same functions of growth and production of ammonia.
12. A method of providing plants with a source of fixed nitrogen which comprises introducing a mutant nitrogen fixing bacterium according to Claim 1, 2, 3 or 4 or produced by a method claimed in any one of Claims 5 to 11 into nitrogen fixing association with plant tissue.
13. A method according to Claim 12 wherein the mutant bacteria are introduced to the soil before or after planting.
14. A method according to Claim 12 wherein the mutant bacteria are introduced to the plant before or after planting.
15. A method according to Claim 12 wherein the mutant bacteria are introduced to the seed before or after planting.
16. A method according to Claim 12 wherein the bacteria are introduced as an aerosol or liquid.
17. A method according to Claim 12 wherein the bacteria are capable of binding to lectins produced by leguminous plants.
18. A method according to Claim 12 wherein the genes providing ability to bind to lectin are introduced into Azotobacteria vinelandii.
19. A method according to Claim 18 wherein the genes are obtained from Rhizobium trifolium and Rhizobium leauminosarum.
20. Plants wherein the source of fixed nitrogen is supplied by a method according to any of Claims 12-19.
21. A mutant nifL gene for insertion into a recipient bacterium by gene replacement.
22. A gene according to Claim 21 characterised in that it originates from the strain of A vinelandii deposited at the
National Collection of Industrial and Marine Bacteria Ltd.,
Aberdeen, Scotland, UK on 30th August 1991 under the accession number 40438 or a mutant or variant thereof having the same functions of growth and production of ammonia.
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9119255A GB2259302A (en) | 1991-09-09 | 1991-09-09 | Mutant nitrogen fixing bacterium |
| JP4505552A JPH07501201A (en) | 1991-09-09 | 1992-03-02 | Ammonia production by recombinant nitrogen-fixing bacteria |
| PCT/GB1992/000368 WO1993005154A1 (en) | 1991-09-09 | 1992-03-02 | Ammonia production by a recombinant nitrogen fixing bacteria |
| NZ241826A NZ241826A (en) | 1991-09-09 | 1992-03-04 | Nitrogen fixing bacteria with mutation in nifl gene and its preparation and uses |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9119255A GB2259302A (en) | 1991-09-09 | 1991-09-09 | Mutant nitrogen fixing bacterium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB9119255D0 GB9119255D0 (en) | 1991-10-23 |
| GB2259302A true GB2259302A (en) | 1993-03-10 |
Family
ID=10701141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9119255A Withdrawn GB2259302A (en) | 1991-09-09 | 1991-09-09 | Mutant nitrogen fixing bacterium |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPH07501201A (en) |
| GB (1) | GB2259302A (en) |
| NZ (1) | NZ241826A (en) |
| WO (1) | WO1993005154A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7470427B2 (en) * | 2001-08-31 | 2008-12-30 | The University Of Nottingham | Systemic non-nodular endosymbiotic nitrogen fixation in plants |
| WO2013132518A1 (en) * | 2012-03-03 | 2013-09-12 | Department Of Biotechnology Ministry Of Science & Technology | Recombinant nitrogen fixing microorganism and uses thereof |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2721153T3 (en) | 2011-06-16 | 2020-03-31 | The Regents Of The University Of California | Synthetic gene clusters |
| WO2014071182A1 (en) | 2012-11-01 | 2014-05-08 | Massachusetts Institute Of Technology | Directed evolution of synthetic gene cluster |
| KR102197507B1 (en) * | 2015-07-13 | 2020-12-31 | 피벗 바이오, 인크. | Methods and compositions for improving plant traits |
| WO2017062412A1 (en) | 2015-10-05 | 2017-04-13 | Massachusetts Institute Of Technology | Nitrogen fixation using refactored nif clusters |
| CN116904333A (en) | 2017-01-12 | 2023-10-20 | 皮沃特生物公司 | Methods and compositions for improving plant traits |
| EP3701040A4 (en) | 2017-10-25 | 2021-08-25 | Pivot Bio, Inc. | METHODS AND COMPOSITIONS FOR IMPROVING NITROGENIC MICROBES THAT FIX NITROGEN |
| AU2018354338B2 (en) | 2017-10-25 | 2023-10-26 | Pivot Bio, Inc. | Gene targets for nitrogen fixation targeting for improving plant traits |
| EP3814302A4 (en) | 2018-06-27 | 2022-06-29 | Pivot Bio, Inc. | Agricultural compositions comprising remodeled nitrogen fixing microbes |
| WO2020014498A1 (en) | 2018-07-11 | 2020-01-16 | Pivot Bio, Inc. | Temporally and spatially targeted dynamic nitrogen delivery by remodeled microbes |
| US12421519B2 (en) | 2019-01-07 | 2025-09-23 | Pivot Bio, Inc. | Plant colonization assays using natural microbial barcodes |
| JP2022519289A (en) * | 2019-02-05 | 2022-03-22 | ピボット バイオ, インコーポレイテッド | Improve crop yield consistency through biological nitrogen fixation |
| US12281299B2 (en) | 2019-03-19 | 2025-04-22 | Massachusetts Institute Of Technology | Control of nitrogen fixation in rhizobia that associate with cereals |
| CA3154903A1 (en) * | 2019-09-18 | 2021-03-25 | Wisconsin Alumni Research Foundation | Genetically modified nitrogen fixing bacteria and uses thereof |
| US12281980B2 (en) | 2020-05-01 | 2025-04-22 | Pivot Bio, Inc. | Measurement of nitrogen fixation and incorporation |
| WO2024121869A1 (en) * | 2022-12-09 | 2024-06-13 | Fertis India Pvt. Ltd. | Genetic modification of microbes for production of nitrogen-containing, non-carbon compounds |
| WO2024225486A1 (en) * | 2023-04-27 | 2024-10-31 | キッコーマン株式会社 | Nitrogen-fixing bacterium, and method for producing ammonia-, amino acid- or protein-containing culture using nitrogen-fixing bacterium |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2494297A1 (en) * | 1980-11-18 | 1982-05-21 | Pasteur Institut | Cells and microorganisms having nitrogen fixation genes - and a NIFLA operon, have under-gone a mutation to confer pheno-type NIF-C, and have nitrogenase activity in the presence of ammonium ions |
| EP0339830A3 (en) * | 1988-04-14 | 1990-01-17 | Biotechnica International, Inc. | Improved biological nitrogen fixation |
-
1991
- 1991-09-09 GB GB9119255A patent/GB2259302A/en not_active Withdrawn
-
1992
- 1992-03-02 WO PCT/GB1992/000368 patent/WO1993005154A1/en active Search and Examination
- 1992-03-02 JP JP4505552A patent/JPH07501201A/en active Pending
- 1992-03-04 NZ NZ241826A patent/NZ241826A/en unknown
Non-Patent Citations (9)
| Title |
|---|
| Abstr.Annu.Meet.Am.Soc.Microbiol.1984,84 Meet,170,Abs.K140 * |
| Arch.Microbiol.1989,151(2),180-182 * |
| Biochimie 1983,65,53-63 * |
| EMBO J.1982,12(1),1551-1558 * |
| Eur.J.Biochem 1990,187,353-360 * |
| Gene 1986,45,281-288 * |
| J.Bacteriology 1980,144(2),744-751 * |
| Mol.Gen.Genet.1983,191,485-491 * |
| Mol.Gen.Genet.1985,198,198-206 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7470427B2 (en) * | 2001-08-31 | 2008-12-30 | The University Of Nottingham | Systemic non-nodular endosymbiotic nitrogen fixation in plants |
| US8137665B2 (en) | 2001-08-31 | 2012-03-20 | The University Of Nottingham | Systemic non-nodular endosymbiotic nitrogen fixation in plants |
| WO2013132518A1 (en) * | 2012-03-03 | 2013-09-12 | Department Of Biotechnology Ministry Of Science & Technology | Recombinant nitrogen fixing microorganism and uses thereof |
| US9321697B2 (en) | 2012-03-03 | 2016-04-26 | Department of Biotechnology Ministry of Science & Technology+Jawaharlal Nehru University | Recombinant nitrogen fixing microorganism and uses thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| NZ241826A (en) | 1993-05-26 |
| JPH07501201A (en) | 1995-02-09 |
| GB9119255D0 (en) | 1991-10-23 |
| WO1993005154A1 (en) | 1993-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2259302A (en) | Mutant nitrogen fixing bacterium | |
| Bali et al. | Excretion of ammonium by a nifL mutant of Azotobacter vinelandii fixing nitrogen | |
| Contesto et al. | Effects of rhizobacterial ACC deaminase activity on Arabidopsis indicate that ethylene mediates local root responses to plant growth-promoting rhizobacteria | |
| Dekkers et al. | A two-component system plays an important role in the root-colonizing ability of Pseudomonas fluorescens strain WCS365 | |
| Bezzate et al. | Disruption of the Paenibacillus polymyxa levansucrase gene impairs its ability to aggregate soil in the wheat rhizosphere | |
| Gutterson | Microbial fungicides: recent approaches to elucidating mechanisms | |
| Sarniguet et al. | The sigma factor sigma s affects antibiotic production and biological control activity of Pseudomonas fluorescens Pf-5. | |
| Lereclus et al. | Overproduction of encapsulated insecticidal crystal proteins in a Bacillus thuringiensis spoOA mutant | |
| Holguin et al. | Genetics and molecular biology of Azospirillum | |
| Bender et al. | Characterization of the genes controlling the biosynthesis of the polyketide phytotoxin coronatine including conjugation between coronafacic and coronamic acid | |
| Margot et al. | The gene of the N‐acetylglucosaminidase, a Bacillus subtilis 168 cell wall hydrolase not involved in vegetative cell autolysis | |
| US9321697B2 (en) | Recombinant nitrogen fixing microorganism and uses thereof | |
| Evans et al. | Hydrogen recycling in nodules affects nitrogen fixation and growth of soybeans | |
| Gao et al. | The phosphotransferase system gene ptsH plays an important role in MnSOD production, biofilm formation, swarming motility, and root colonization in Bacillus cereus 905 | |
| CZ216699A3 (en) | Genes coding for amino acid deacetylases with specification for N-acetyl-L-phosphinothricin, method of their isolation and their use | |
| Colnaghi et al. | Strategies for increased ammonium production in free-living or plant associated nitrogen fixing bacteria | |
| Peralta et al. | Engineering the nifH promoter region and abolishing poly-β-hydroxybutyrate accumulation in Rhizobium etli enhance nitrogen fixation in symbiosis with Phaseolus vulgaris | |
| Gibson et al. | Analysis of the cbbXYZ operon in Rhodobacter sphaeroides | |
| Parniske et al. | ExoB mutants of Bradyrhizobium japonicum with reduced competitiveness for nodulation of Glycine max | |
| Gao et al. | The phosphotransferase system gene ptsI in Bacillus cereus regulates expression of sodA2 and contributes to colonization of wheat roots | |
| Thomas et al. | Environmentally directed mutations in the dehalogenase system of Pseudomonas putida strain PP3 | |
| Ruckdäschel et al. | AROMATIC AMINO ACID AMINOTRANSFERASES OF AZOSPIRILLUM LIPO-FERUM ANO THEIR POSSIBLE INVOLVEMENT IN IAA BIOSYNTHESIS | |
| Van Soom et al. | Hydrogenase in Bradyrhizobium japonicum: genetics, regulation and effect on plant growth | |
| Kriete et al. | Influence of the herbicide phosphinothricin on growth and nodulation capacity of Rhizobium meliloti | |
| Morett et al. | Impaired nitrogen fixation and glutamine synthesis in methionine sulfoximine sensitive (MSs) mutants of Rhizobium phaseoli |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |